Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. [electronic resource]
Producer: 20160421Description: 102 p. digitalISSN:- 1475-2840
- Aged
- Biomarkers -- blood
- Biomechanical Phenomena
- Blood Glucose -- drug effects
- Coronary Artery Disease -- complications
- Diabetes Mellitus, Type 2 -- blood
- Diabetic Cardiomyopathies -- diagnosis
- Echocardiography, Doppler, Color
- Echocardiography, Stress
- Female
- Glucagon-Like Peptide 1 -- administration & dosage
- Glucose Clamp Technique
- Humans
- Hyperglycemia -- blood
- Incretins -- administration & dosage
- Infusions, Intravenous
- Insulin -- blood
- Male
- Middle Aged
- Myocardial Contraction -- drug effects
- Peptide Fragments -- administration & dosage
- Stroke Volume -- drug effects
- Ventricular Dysfunction, Left -- diagnosis
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.